癌变·畸变·突变 ›› 2017, Vol. 29 ›› Issue (2): 87-90,95.doi: 10.3969/j.issn.1004-616x.2017.02.002

• 论著 • 上一篇    下一篇

结直肠癌组织中KIAA1522的表达及临床意义

刘婷婷1, 梁建伟2, 余竟1, 常晨1, 郝佳洁1, 蔡岩1, 周志祥2, 王明荣1, 张彤彤3, 张钰1   

  1. 1. 国家癌症中心/中国医学科学院北京协和医学院肿瘤医院分子肿瘤学国家重点实验室, 北京 100021;
    2. 国家癌症中心/中国医学科学院北京协和医学院肿瘤医院腹部外科, 北京 100021;
    3. 成都市第三人民医院实验医学研究部, 四川 成都 610031
  • 收稿日期:2016-11-23 修回日期:2017-01-12 出版日期:2017-03-31 发布日期:2017-03-31
  • 通讯作者: 张钰,E-mail:zhangyu909@126.com;张彤彤,E-mail:163zttong@163.com E-mail:zhangyu909@126.com;163zttong@163.com
  • 作者简介:刘婷婷,E-mail:18809883150@163.com。
  • 基金资助:

    国家自然科学基金面上项目(81472562);国家重点研发计划项目精准医学研究专项(2016YFC0905300)

Significance in expression of KIAA1522 in colorectal cancer

LIU Tingting1, LIANG Jianwei2, YU Jing1, CHANG Chen1, HAO Jiajie1, CAI Yan1, ZHOU Zhixiang2, WANG Mingrong1, ZHANG Tongtong3, ZHANG Yu1   

  1. 1. State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021;
    2. Abdominal Surgery Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021;
    3. Medical Research Center, The Third People's Hospital of Chengdu, Chengdu 610031, Sichuan, China
  • Received:2016-11-23 Revised:2017-01-12 Online:2017-03-31 Published:2017-03-31

摘要:

目的:检测KIAA1522蛋白在结直肠癌中的表达变化并评价其临床意义。方法:应用组织芯片-免疫组织化学染色技术,检测96例结直肠癌组织及其配对癌旁正常组织中KIAA1522蛋白的表达情况,并对其阳性表达率与结直肠癌临床病理指标及患者预后的关系进行统计学分析。结果:KIAA1522蛋白在癌旁正常结直肠上皮细胞中主要定位于细胞浆,阳性表达率为12.5%(12/96),而在结直肠癌组织中KIAA1522蛋白阳性表达率为81.3%(78/96),两者间差异显著(P < 0.05)。Kaplan-Meier生存分析结果显示,KIAA1522蛋白阳性表达与结直肠癌患者术后3年无瘤生存期短显著正相关(P=0.017,Log-rank检验)。多因素Cox回归分析结果表明,KIAA1522蛋白阳性表达是结直肠癌患者预后不良的独立预测因素(P=0.020)。卡方检验的分析结果显示,KIAA1522蛋白阳性表达与肿瘤的远处转移正相关(P=0.012,Fisher精确检验)。结论:KIAA1522在结直肠癌组织中的阳性表达与肿瘤的远处转移及患者术后生存期短显著相关,可能作为预测结直肠癌患者预后及转移的潜在分子标志。

关键词: 结直肠癌, KIAA1522, 转移, 预后

Abstract:

OBJECTIVE: To investigate expression status of KIAA1522 in colorectal cancer (CRC),and its correlation with clinicopathological features and prognosis. METHODS: Expression of KIAA1522 protein was determined with tissue microarrays-immunohistochemistry (TMA-IHC) technique in surgically-resected colorectal cancer tissues and adjacent normal epithelia from 96 patients. The relationship between KIAA1522 expression and clinicopathological characteristics and prognosis of the patients were analyzed. RESULTS: KIAA1522 protein was mainly localized in the cytoplasm of colorectal epithelial cells. While only 12.5% (12/96) of normal colorectal epithelia displayed positive staining,81.3% (78/96) of CRC specimens showed over-expression of KIAA1522. The difference between them was highly significant (P < 0.001). Kaplan-Meier survival analysis revealed that high level of KIAA1522 expression was correlated with lower 3-year disease free survival (DFS) rate of CRC patients (P=0.017). Further more,KIAA1522 up-regulation was significantly correlated with distant metastasis (P=0.012). More importantly,Cox regression analysis indicated that KIAA1522 protein expression was an independent prognosis factor in CRC (P=0.020). CONCLUSION: KIAA1522 was frequently up-regulated in CRC,and its over-expression was significantly correlated with distant metastasis and poor prognostic,thus KIAA1522 over-expression may served as a new prognostic marker in colorectal cancer.

Key words: colorectal cancer, KIAA1522, metastasis, prognosis

中图分类号: